Pharma channel feed – Endpoints News

Pharma channel feed

Avalo Therapeutics to lay off 33% of staff amidst market struggles and penny stock status

4 years ago

Intercept sells ex-US rights to PBC drug as it gears up for a second-chance shot at NASH

4 years ago

Idorsia rolls out insomnia med Quviviq with sales team, digital marketing and DTC in the works

4 years ago

In wake of massive year-over-year growth, Moderna reserves its buyers seat at the global deals table

4 years ago

Amazon subsidiary PillPack reaches a settlement with US government and will have to shell out over $5.6M

4 years ago

Novartis' compassionate use requests worldwide: Just 0.5% came from lower-middle- and low-income countries

4 years ago

Novotech extends arms into US with acquisition of a South Carolina CRO

4 years ago

Former FDA chief of staff steps into VP role at Philip Morris as CDMO pivot continues

4 years ago

AstraZeneca poised to snag fast approval for a frontline use of Imfinzi, adding to its growing oncology portfolio

4 years ago

AbbVie pulls back the curtain on its leaders across disciplines in conversational Q&A series ‘Magnified’

4 years ago

An upstart protein degradation contender adds Merck KGaA and Bristol Myers to its list of Big Pharma backers

4 years ago

Takeda GI spinout nabs approval for only drug — and pivots to a quick raise

4 years ago

Pfizer’s Covid story — and revenue spree — continue with $54B vaccine and pill in spotlight again

4 years ago

FDA hits Miami University in Ohio with a warning letter over falsified data

4 years ago

Two investors team up for CordenPharma buyout following mRNA vaccine success

4 years ago

Where did all the FDA adcomms go? New research digs into steep drop in meetings

4 years ago

Supernus' nonstimulant ADHD drug Qelbree gains approval for adult use

4 years ago

MarketingRx roundup: AbbVie launches new migraine TV ad with tennis star; Allergan enlists celeb for vision med Vuity

4 years ago

Sanofi and Regeneron grow marketing for Dupixent's ‘do list’ with asthma campaign evolution

4 years ago

Fifth individual charged in conspiracy to steal GlaxoSmithKline trade secrets, faces up to 10-year sentence

4 years ago

GSK beat six other companies to the Sierra deal table and prevailed after initial $46 per share bid

4 years ago

A year after CRL, Acadia is going back to bat for Nuplazid at the FDA

4 years ago

Updated: Gilead collects 5th priority review voucher as public advocacy group urged the company to relinquish it

4 years ago

After Roundup debacle, Bayer's shareholders vote against management pay scheme

4 years ago

First page Previous page 203 204 205206207 208 209 Next page Last page